The global demand on agri-food systems continues to grow, necessitating innovative strategies for increasing agricultural ...

New treatments based on biological molecules like RNA give scientists unprecedented control over how cells function. But ...

The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...

Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi ...

In Regents of the University of California v. Broad Institute, Inc., the Federal Circuit addressed the issue of conception and reduction to ...

Empa has developed polymer-based, MRI-compatible electrode cables in collaboration with Swiss company TI Solutions AG, addressing long-standing safety and performance challenges associated with using ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and implications for molecular biology research.

Company’s first clinical-stage program headlines a diverse and novel pipeline poised to deliver 1-2 new investigational drugs into the clinic annually CAMBRIDGE, Mass.--(BUSINESS WIRE)--City ...

Founded in 1992, Sirna Therapeutics was one of the earliest biotechnology companies focused on developing therapeutics based on RNA interference (RNAi), specifically using small interfering RNA (siRNA ...

Advancing a once-annual preventive RNAi medicine designed to reduce the two key drivers of cardiovascular disease: LDL-C and blood pressure Filed application for COR-1004, a novel siRNA targeting ...